Maxcyte (MXCT) Long-Term Investments (2023 - 2026)

Maxcyte (MXCT) has 4 years of Long-Term Investments data on file, last reported at $40.8 million in Q1 2026.

• On a quarterly basis, Long-Term Investments rose 12.05% year-over-year to $40.8 million in Q1 2026; TTM through Mar 2026 was $40.8 million, a 12.05% increase from a year earlier, with the FY2025 full-year figure at $52.6 million, up 46.92% from the prior year.
• Long-Term Investments for Q1 2026 stood at $40.8 million, down from $52.6 million in the prior quarter.
• Over the last five years, Long-Term Investments for MXCT reached as high as $52.6 million in Q4 2025 and fell as low as $18.4 million in Q3 2023.
• Historically, Long-Term Investments has averaged $40.7 million across 4 years, with a median of $42.5 million in 2024.
• Across the five-year window, Long-Term Investments jumped 132.23% in 2024 and decreased 19.12% in 2025, its largest moves.
• Year by year, Long-Term Investments stood at $42.9 million in 2023, then dropped by 16.67% to $35.8 million in 2024, then soared by 46.92% to $52.6 million in 2025, then retreated by 22.37% to $40.8 million in 2026.
• Per Business Quant data, the three most recent Long-Term Investments figures were $40.8 million in Q1 2026, $52.6 million in Q4 2025, and $52.3 million in Q3 2025.